Correction to: npj Precision Oncology https://doi.org/10.1038/s41698-021-00206-y, published online 20 July 2021
The original version of this Article contained a typographical error in the pie chart label of Figure 2c. This has now been corrected in the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Westphalen, C.B., Krebs, M.G., Le Tourneau, C. et al. Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population. npj Precis. Onc. 5, 86 (2021). https://doi.org/10.1038/s41698-021-00222-y
Published:
Version of record:
DOI: https://doi.org/10.1038/s41698-021-00222-y
This article is cited by
-
Digestive cancers: mechanisms, therapeutics and management
Signal Transduction and Targeted Therapy (2025)
-
Die Bedeutung Entitäten-agnostischer Zulassungen im klinischen Alltag
InFo Hämatologie + Onkologie (2023)
